Silver Book

Silver Book Fact

Healthcare costs of atrial fibrillation

Atrial fibrillation (AF) is a major economic burden for society with the biggest cost driver being hospitalizations—accounting for 52% of costs. Drugs for AF account for 23% of costs, consultations at 9%, further investigations at 8%, loss of work at 6%, and paramedical procedures at 2%.

Le Heuzey, J-Y, O Paziaud, O Piot, SM Ait, X Copie, T Lavergne, and L Guize. Cost of Care Distribution in Atrial Fibrillation Patients: The COCAF study. Am Heart J. 2004; 147(1): 121-6. http://www.ahjonline.com/article/S0002-8703%2803%2900524-6/abstract

Reference

Title
Cost of Care Distribution in Atrial Fibrillation Patients: The COCAF study
Publication
Am Heart J
Publication Date
2004
Authors
Le Heuzey, J-Y, O Paziaud, O Piot, SM Ait, X Copie, T Lavergne, and L Guize
Volume & Issue
Volume 147, Issue 1
Pages
121-6
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • AFib-related stroke and disability
    Stroke is very disabling and individuals recovering from a stroke who also have AFib have a higher risk of remaining disable or handicapped compared to stroke patients without AFib.  
  • Medical care rates during the year following an AFib diagnosis
    A study of Medicare beneficiaries found that during the year following an atrial fibrillation (AF) diagnosis: • 28% of AF patients (versus 7% of non-AF patients) had 3 or more hospital…  
  • Distribution of inpatient and selected outpatient costs for treating atrial fibrillation
    Distribution of inpatient and selected outpatient costs for treating atrial fibrillation  
  • Hospital readmission rates among AFib patients
    In the year following initial hospitalization for atrial fibrillation (AF), 12.5% of chronic AF patients were readmitted for AF—17.6% of readmissions occurred within 1 month. Among newly-diagnosed patients, 10.1% were…  
  • AFib attributed stroke rate by age
    The percentage of strokes attributable to atrial fibrillation increases from 1.5% at ages 50 to 59, to 23.5% at ages 80 to 89.